D eep brain stimulation was first introduced for the treatment of essential tremor in 1991. 3 Over the past decade, a number of studies have been published confirming the safety and efficacy of stimulation of the thalamic VIM for the treatment of essential tremor in long-term (1-6-year) follow-up. 26, 28, 32 However, some series have reported that 13-40% of these patients may become refractory to treatment over time. 3, 10, 16 Review of the literature suggests that there are 2 groups of patients with stimulation failure-those who lose benefit in the short term and those with diminished efficacy in the long term. Generally, the cause of stimulation failure in patients who have short-term failures is attributed to suboptimal lead location. The cause of stimulation failure in the second group of patients has not been as well defined, and discrepancy in failure rates may be secondary to different definitions of failure. Possible causes such as disease progression and tolerance to the antitremor effects of VIM DBS have been proposed. 3, 27 It remains unclear whether suboptimal lead location may also lead to late stimulation failure. 27 In the current study, we examined our experience with patients undergoing DBS who had initial satisfactory tremor control and subsequently lost stimulation efficacy.
Methods
We reviewed the medical and imaging records of all patients with essential tremor who underwent VIM DBS in the Rush University movement disorders surgery program between 2001 and 2006 and included all patients who had > 1-year postoperative follow-up and had success with tremor control throughout that initial follow-up. Prior to selection for DBS, patients were referred to our center after undergoing extensive preoperative neurological workup to confirm their diagnosis of essential tremor and failure of conservative medical therapy. A single movement disorders neurologist (L.V.) performed all preoperative tremor testing using the Fahn-Tolosa-Marin TRS. 6 All procedures were performed by a single surgeon at a single institution (R.A.E.B.). Twenty-five patients underwent stereotactic electrode placement in the VIM with Leksell frame placement (Elekta Instruments), and the remaining 2 patients had placement using the Nex-frame system (IGN/Medtronic). All patients underwent Gd-enhanced MR imaging. The patients who underwent the procedure with the aid of the Nex-frame system also underwent CT scanning. Stereotactic planning was based on targeting of the VC subnucleus of the thalamus. The initial target was generally 4 mm anterior to the PC, 11-12 mm laterally plus half the width of the third ventricle, and at the depth of the AC-PC line. The typical angles ranged from 30 to 40° in the sagittal plane and were < 10° in the coronal plane. Intraoperatively, microelectrode recording was used. Once the border between the VC and VIM was identified, the electrode was generally implanted 2-4 mm anterior to this border. Microstimulation was then performed to evaluate side effects. Once the optimal trajectory was selected, the DBS electrode was implanted (model 3387 in 14 cases and model 3389 in 17 cases; Medtronic, Inc.), and macrostimulation was performed to confirm the presence of benefit and the absence of side effects. The positions of the electrodes were documented with postoperative MR imaging. The patients underwent internal pulse generator (Soletra, Medtronic, Inc.) placement during a separate sitting and returned for initial programming ~ 3-4 weeks after the first surgery.
Programming was performed by the same movement disorders neurologist (L.V.). Optimization of stimulation parameters was based in part by assessing the patients' handwriting and having them draw an Archimedes spiral with the contralateral arm. Based on definitions in the TRS, normal function (no tremor) was rated as 0, and severe tremor was rated as 4. The tremor scores from the most recent follow-up were used in statistical analyses.
Perioperative records were also reviewed. Data concerning intraoperative values (sensorimotor driving during microelectrode recordings, side effects with micro-and mac rostimulation, intraoperative fluoroscopy findings, and electrode location on postoperative MR imaging) were evaluated. All MR imaging data sets were formatted parallel to the AC-PC line and orthogonal to the midsagittal plane. The lateral coordinate was measured in mm from the midline and in mm from the ipsilateral wall of the third ventricle. The AP coordinate was measured in mm anterior to PC.
Patients with continued efficacy were first compared with patients with stimulation failure, defined as loss of meaningful tremor relief. Realizing that it was inaccurate to deem patients who required voltages high enough to shorten battery life complete treatment successes, we then compared patients with continued efficacy to patients with less satisfactory outcomes and included those with stimulation failure and leads requiring voltages > 3.6 V for effective tremor control. Data were analyzed using the Student t-test and Fisher exact test. The Wilcoxon signed-rank test was used for analysis of tremor scores. A probability value < 0.05 was considered statistically significant.
Results

Patient Demographics
Twenty-eight patients underwent DBS placement for essential tremor between 2001 and 2006 at our institution. One of these patients had early stimulation failure and required repositioning of the DBS electrode within the 1st year after surgery. He had excellent tremor control following the second operation. The remaining 27 patients had satisfactory tremor control for > 1 year; thus, 31 DBS leads in 27 patients were included in the study. One of these 27 patients was excluded from statistical analysis as the stimulator was never turned on due to persistent excellent tremor control with microthalamotomy received at the time of surgery. Of the remaining patients, 4 had bilateral implants and 22 had unilateral implants. The patients who had bilateral implants had the electrodes placed in a staged fashion, because of the risk of dysarthria and disequilibrium associated with simultaneously placed VIM electrodes. 26 The mean age of patients at the time of surgery was 67.0 ± 13.3 years (range 35-85 years). The mean follow-up time was 40 ± 17 months (range 13-66 months). Patient demographics are shown in Table 1 .
Postoperatively, there was a significant improvement in both tremor subscale scores (p < 0.001). Specifically, the mean preoperative tremor scores on the writing and drawing subscales were 3.24 ± 0.83 and 3.17 ± 0.93, respective- * One of the study patients was excluded from statistical analysis as the stimulator was never turned on due to persistent excellent tremor control with microthalamotomy received at the time of surgery. Mean values are expressed as the means � standard deviations. Abbreviations: FU = follow-up; LE = lower extremity; UE = upper extremity.
ly. The mean postoperative scores were 0.8 ± 0.82 and 0.83 ± 0.83, respectively. Seventy percent of patients remained off medication or on < 50% of their preoperative doses. At most recent follow-up, 58% of patients had optimal results with monopolar stimulation and 42% bipolar stimulation. Fifty percent of patients did not require voltage changes. Twenty-seven percent of patients increased their amplitude between 1 and 2 V over the course of follow-up. The remaining 23% of patients have had increases in amplitude > 2 V in their reprogramming sessions. See Table 2 for programming parameters.
Stimulation Failure
Four patients eventually lost efficacy of their stimulation. Stimulation failure was defined as inability to maintain satisfactory tremor control in daily living without significant side effects. Resumption of stimulation after temporary discontinuation, that is, stimulation holidays, was not beneficial in improving tremor control. The mean time until stimulation failure was 39 months (range 19-58 months). There was no statistical difference between groups in age (p = 0.49), duration of disease (p = 0.23), severity of tremor on TRS (p = 0.23), or duration of time since surgery (p = 0.44). Data from microelectrode recordings, specifically the number and type of kinesthetic cells activated and the reduction of tremor with intraoperative stimulation, were not statistically different between groups.
There was no significant difference in lead location on postoperative MR imaging between groups. The mean lateral lead location from midline was 13.4 ± 1.7 mm in the group with continued efficacy and 13.5 ± 2.0 mm in the group who lost efficacy (p = 0.45). Similarly, there was no difference in mean lateral lead location from the ipsilateral wall of the third ventricle (9.8 ± 1.8 and 9.5 ± 0.5 mm, respectively; p = 0.34). The mean AP lead location was 5.9 ± 1.7 mm anterior to the PC in the group with continued efficacy and 4.6 ± 1.1 mm in the group who lost efficacy (p = 0.06). There was no difference between groups in the z coordinate (0.05 ± 1.5 mm in the group with continued efficacy and 0.0 ± 2.3 mm in the group who lost efficacy; p = 0.47). Review of the angles of the electrodes both vertical to intercommissural plane and horizontal to that plane revealed no significant difference between groups (p = 0.09).
Intraoperative fluoroscopy was performed after each microelectrode track and after final placement of the DBS lead to determine electrode position in the AP plane. Any alteration in fluoroscopic images between the microelectrode in the electrophysiologically selected target and the DBS lead was documented. A 1-2-mm deviation between the electrophysiologically determined target and final lead placement occurred in 3 of 4 leads in patients who experienced stimulation failure; in patients with continued DBS efficacy, only 2 of 22 leads were noted to have similar deviation (p = 0.018). Of note, the fourth patient who grew tolerant to stimulation effects was noted to have developed a resting tremor.
Increasing Voltage Requirements
We then analyzed data in patients with failure combined with those with less satisfactory outcomes, that is, voltage parameters that had increased to a mean of > 3.6 V (range 4.1-10 V) over time. There was no significant difference in preoperative factors between this group of less satisfactory outcomes (10 patients) and the group with good outcomes (10 patients). Postoperative MR imaging revealed no significant differences between groups in the y and z coordinates (p = 0.49 and p = 0.10, respectively). Similarly, no differences were seen based on angle of the electrode (p = 0.19 vertical, p = 0.36 horizontal). There was a significant difference between groups in the x coordinate, expressed as distance from midline (p = 0.01) and a trend when expressed as distance from the wall for the third ventricle (p = 0.07). Leads with continued efficacy tended to be more medial to midline (12.9 ± 1.6 mm) than those in patients with less satisfactory outcomes (14.3 ± 1.6 mm).
Five of 10 leads placed in the suboptimal outcomes group were noted to have movement of the DBS electrode on intraoperative fluoroscopy, although 1 of 20 leads in patients with good outcome had movement (p = 0.005). These data are summarized in Table 3 . 
Discussion
Failures in Thalamotomy and DBS
Thalamotomy for the treatment of essential tremor resulted in significant tremor reduction, ranging from 66 to 94%. 7, 8, 12, 22, 23, 25, 31 However, the complication rate was 1-25% 7, 8, 22 and it was even greater in patients who under went bilateral procedures. 21, 30 Thus, the introduction of thalamic DBS for essential tremor was met with enthusiasm.
3
In 2000, a randomized controlled trial of VIM DBS and thalamotomy revealed that both modalities had equivalent efficacy in tremor suppression at 6-month follow-up, but confirmed that thalamic DBS had fewer adverse effects. 29 Although the effects of VIM DBS on tremor and daily living are often long-lasting, 9,26,28,32 a significant subset of patients has been noted to become refractory to treatment over time. 3, 10, 15, 16 Review of the existing literature on VIM stimulation for essential tremor suggests that there are 2 groups of patients who have stimulation failure: those who receive minimal to no benefit with stimulation essentially immediately after surgery and those who lose stimulation efficacy over time. The first category of patients has generally undergone an additional procedure, DBS or thalamotomy, within 1 year of their initial surgery with good benefit. 14, 24 Thus, in all likelihood, these initial failures were due to suboptimal location. Early failure has also been reported in the thalamotomy literature; one study of 37 thalamotomies with follow-up up to 13 months revealed 5 failures in that time frame, 1 which again improved with repeated operation and was attributed to location/lesion volume.
The second group of patients with stimulation failure is less well understood. These patients initially received good benefit from their stimulation, but then subsequent ly have seen their tremor return. Despite aggressive programming at increasing stimulation intensities, it be comes progressively more difficult to control tremor without inducing intolerable side effects. Because the purpose of this study was to examine the second group of patients, only patients who were controlled for > 1 year were included. Published outcome data concerning patients with essential tremor with > 1 year of follow-up and thus comparable to our outcome data are shown in Table 4 . To summarize, tremor worsening occurred in 13-40% of patients. 10, [14] [15] [16] [17] 20, [26] [27] [28] 32, 34 Differences in definition of failure may have contributed to the variability of long-term success. Late failure in the thalamotomy literature also varied from study to study. Some studies reported no decreases in tremor suppression whereas others reported rates up to 20% (Table 5) . 1, 22, 23, 31 Thus, tolerance to stimulation cannot be the sole cause of late failure in patients undergoing surgical treatment of essential tremor.
Relative Role of Tolerance
Tolerance to stimulation, however, does likely play some role, as many patients need increased voltages to maintain satisfactory tremor control over time. 10, 14, 15, 17, 20, 26, 28, 32, 34 More than half the patients in one series of 11 patients ne cessitated higher parameters to maintain satisfactory tremor control, which was reported as better than baseline, but not as robust as their initial improvements following surgery. 17 Another series of 36 patients with 17-month follow-up dem onstrated significant changes in stimulation amplitude (p < 0.001) and frequency (p < 0.05) at 1 year; 10 the percentage of patients requiring bipolar stimulation or monopolar stimulation with multiple contacts also increased. 10 An additional group reported that amplitude was increased over time by ≥ 1 V in 8 of 26 patients and that 14 patients required voltages of ≥ 3.6 V for effective tremor control. 26 In general, the rate of increase in amplitude needed to control tremor in essential tremor is higher than in tremor associated with Parkinson disease or poststroke tremor. 34 In 5 of our 27 leads with continued efficacy, we needed to use bipolar and multicontact monopolar stimulation to maintain satisfactory tremor control without causing adverse effects.
Although the basis of DBS for the treatment of essential tremor remains debated, it is generally believed that there are areas of tremor cells that fire in conjunction with electromyographic tremor 18, 19 and may act as a "tremorogenic" pacemaker. It has been proposed that DBS disrupts local neural activities essential for tremor production and spread by inhibiting the afferent tremor signals or by altering the excitability of incoming thalamic neurons. 2, 4, 5 The development of tolerance suggests that over time the ability of stimulation to maintain these effects wanes. Con versely, Kumar et al. 16 reported that 2 of 5 patients whom they observed for 2 years had progressively better tremor control and hypothesized that this was a result of slowly progressive thalamic lesioning or chronic DBS inducing permanent physiological changes as previously suggested. 11 Thus, the effects of stimulation on tremor cells may be altered over time. One electrophysiological study found that indeed DBS did alter tremor characteristics such as amplitude, tremor frequency at low inertial loads, and regularity. 33 Further electrophysiological studies of the effects of DBS on tremor characteristics over time will no doubt assist in a better understanding of the true nature of this tolerance.
Role of Disease Progression
A second potential cause of late stimulation failure is disease progression. It is not uncommon for patients who have predominantly unilateral tremor to progress over follow-up to have bilateral tremor. Isolated upper-extremity tremors may progress into axial and lower-extremity tremor. However, although more extremities may be affected or an axial component may arise, tremor scores seem to remain stable. Extensive tremor testing both preoperatively and at different time intervals postoperatively with stimulation off has revealed no significant change in tremor score for as long as 5-6 years postoperatively. 26, 32 Because of the relatively small sample size in all series of patients with essential tremor, there is not enough power in the data to draw a definitive conclusion. Again, it would be interesting to electrophysiologically assess patients with essential tremor over time to better answer this question.
Role of Location
The third hypothesis on loss of stimulation benefit is suboptimal location. 13, 27 In a study of 37 patients, leads located outside a 2-mm radius from a statistically determined optimal anatomical locations (AP coordinate: 6.3 mm anterior to the PC, 10.0 mm lateral to the wall of the third ventricle) had only a 17% chance of producing excellent tremor control whereas those within a 2-mm radius of the theoretical optimal target had a 64% likelihood of providing excellent tremor improvement (> 66% change in tremor scores).
27 These authors did state that even within the 2-mm radius of the optimal target, 9% of leads provided poor tremor control (< 33% improvement) and that this group of patients reported initial tremor control that ceased after a period of months despite aggressive reprogramming. We also observed that patients with less satisfactory outcomes had more laterally placed electrodes. Furthermore, our data suggest that even very slight deviations from an electrophysiological target may result in suboptimal results. These differences were clinically relevant as we were not able to increase the voltage or alter other stimulation parameters to maintain stimulation benefit without producing adverse effects. Others have suggested that even these precise anatomical and electrophysiological locations may not be the optimal location if the tremorogenic pacemaker cells are not stimulated. 13 Katayama et al. 13 evaluated 198 tremor cells in patients with essential tremor undergoing DBS that were located anterior to the border between VC and VIM and compared the relationships between tremor cells and electromyographic activity. They found no definitive correlation between cells with electromyographic coherence and ante- In reality, loss of stimulation benefit likely involves a combination of factors, and all 3 hypotheses may be correct on some level. Taken together with previous works, 13, 27, 34 our study suggests that suboptimal location does play a role in long-term failure and offers the evidence that the presence of a millimetric deviation from the optimal electrophysiological target may have affected outcome. However, the fact that these patients did receive benefit for some period of time prior to loss of efficacy suggests that the lead placement was at least initially reasonable and became inadequate until the patient's disease progressed.
Although these findings support the importance of the electrophysiological target, attempts to achieve millimetric repositioning of the DBS electrode following fluoroscopic evidence of suboptimal placement are so technically challenging that we no longer move the electrode < 2 mm because of the presence of the previous track and due to the calibration limitations of the microguide and cannulas. We have had some benefit in eliminating these deviations by using the cannula, which extends to target. However, after placement of this cannula, further electrophysiological assessment is often not possible due to lesion effects. Overall, however, lead placement is most successful when the DBS electrode is placed at the selected site on the first attempt. We found that despite diligent microelectrode recording, the lead may not rest in the precisely determined location as confirmed by intraoperative imaging and suspect that this inaccuracy is secondary to mechanical issues. The use of fluoroscopy only allows us to comment on intraoperative shifts in the AP direction, and thus, the amount of lead shift in the mediolateral position remains unknown. These data merit further investigation and support routine confirmation of the accuracy of equipment.
Conclusions
In this study, we present our experience with patients who had initial satisfactory tremor control with DBS and subsequently lost stimulation efficacy. We found that patients with more laterally placed electrodes tended to have less satisfactory outcomes. Furthermore, we provide preliminary evidence that even a very slight variation from the electrophysiological target determined intraoperatively as evidenced on fluoroscopy may result in the eventual loss of stimulation efficacy. Long-term stimulation failure in patients with essential tremor remains a significant issue and further studies are mandated to determine the relative roles of location, disease progression, and tolerance development.
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